AstraZeneca Taps Source BioScience for Cancer PGx

Source BioScience will provide a lung cancer companion diagnostic service for mutations linked to tyrosine kinase-based treatments.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.